Good MorningThe FOMC gave the market what it wanted: a 50 basis point rate cut, confirming a shift in economic policy and fundamental conditions expected to lead to a sustained period of growth. However, the S&P 500 could not sustain the immediate surge in price action, confirming that the Fed decision was priced into the market and that a top has been reached for stocks. The takeaway is that a sector rotation that began in July may gain momentum and drive increased volatility for the broad market.
Volatility is the operative word, not a downtrend. Investors should now expect a period of consolidation and sideways movement in the S&P 500 as the market exits one group of trades in favor of another. The consolidation could last for months as it takes four to six fiscal quarters for FOMC policy to fully impact the economy. Between now and then, the S&P 500 will likely move within a trading range, with 5,670 as the peak and the bottom as much as 10% lower. Featured: Washington Thinks They Own Your Bank Account (Ad) 
|
Consumer Staples | |
It is impossible to eliminate stock market risk. Risk and volatility are wily beasts and uncontainable, but they can be mitigated. One method is to use low-beta stocks, which tend to be less volatile than the S&P 500 (NYSEARCA: SPY). However, there are better reasons to invest than having a lo... Read the Full Story |
|
From Our Partners | | Unitree's IPO grabbed headlines, but a handful of already-public robotics companies have been quietly delivering results that look nothing like hype.
One robotics-and-testing firm grew quarterly revenue from $686 million to $1.282 billion year over year and broke out above a $422.11 buy point. A warehouse robotics company exited the quarter with a $22.7 billion backlog and $2.0 billion in cash with no debt. A robotic surgery leader placed 431 systems in a single quarter. | | Get the free robotics stock report now. |
|
Markets | | If you are trying to figure out how much money you can make in stocks in one month, you are probably interested in short-term trading. Short-term trading usually refers to day or swing trading, which means timeframes measure from as little as a few minutes to as long as a couple of weeks. Unlike buy... Read the Full Story |
|
Consumer Discretionary | |
Insider buying is an increasingly valuable tool for investors, especially given uncertain economic conditions and high market volatility. Although their activity is never a guarantee of higher share prices, it can help uncover good investments when combined with other metrics. Today's focus is on ... Read the Full Story |
|
From Our Partners | | The Department of Justice recently argued in court that cash is not legally property, raising new questions for savers as federal debt continues to climb.
Your IRA, 401k, and bank accounts are not hidden from view, prompting some Americans to look for ways to keep more control over their own wealth.
A free information kit outlines three strategies people are considering to help shield their savings from future policy changes. | | Get the free information kit and explore savings strategies now |
|
Technology | |
The stock market has had to watch some of its previous darlings in the technology sector underperform in the past couple of weeks; investors can find the industry’s latest victim in shares of Micron Technology Inc. (NASDAQ: MU) as the stock has traded down from its recent high made in August... Read the Full Story |
|
Materials | |
Investors have flocked to safe haven precious metals including gold and silver in recent months, helping to drive the price of each of these metals up by about a third in the last year. Gold in particular continues to hit new all-time highs and trades close to $2,600 per ounce as of mid-September.... Read the Full Story |
|
From Our Partners | | Nearly 2 in 3 Americans fear running out of money more than death - and chasing a $1.5 million nest egg isn't helping.
Tim Plaehn has spent decades helping people build retirement income, and he says the monthly income goal is the only number that matters. His approach could potentially reach that goal with 10x less capital - using a single stock you can buy with one click. | | Watch the short presentation to see how this retirement income strategy works |
|
Markets | |
Smartsheet (NYSE: SMAR) is a smart buy because of its growth, operational quality, cash flow, and capital return. That’s why private equity firms are in talks to buy it; they see deep value in the business and its stock. The takeaway is that Smartsheet will either get taken over at a premium... Read the Full Story |
|
Consumer Staples | |
Rich in antioxidants like Omega 3, magnesium, potassium, fiber, and lutein, as well as nutrients, including vitamins A through E and K, the avocado is a superfood (and a fruit). Last year, the United States imported a new record of 2.8 billion pounds of avocados from Mexico, the world's largest su... Read the Full Story |
|
Industrials | |
NVIDIA's (NASDAQ: NVDA) stock price has skyrocketed in recent years, driven by its association with artificial intelligence (AI) and the massive spending on data center expansion. The AI boom has made NVIDIA a market darling, but its valuation has soared alongside its stock price.
Johnson Contr... Read the Full Story |
|
Communication Services | |
After seven years, over 3,350 patent and patent-pending claims, and more than $1 billion, AST SpaceMobile Inc. (NASDAQ: ASTS) finally launched its Block 1 first five Bluebird satellites on September 12, 2024. The launch went without a hitch, and the satellites are now in low earth orbit. AST Spa... Read the Full Story |
|
Consumer Staples | |
When it comes to stocks in the beauty industry, the first name on the lips of many right now is Ulta (NASDAQ: ULTA). It was recently revealed that legendary investor Warren Buffett purchased shares of Ulta through his company Berkshire Hathaway (NYSE: BRK.B). Understandably, buzz often circulates ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. | | View Today's Stock Pick |
|
